ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684838 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684838; 2) Community: the network communities that were significantly associated with the response to NSC 684838; 3) Molecule: the relationships between components within communities and NSC 684838; 4) MDR: the compounds that were significantly associated with the NSC 684838.

NSC Compound Enrichment Correlation
NSC 648365 Insulin-Methotrexate conjugate 0.0385067071027345 0.29920028
NSC 650262 Null 0.0385067071027345 -0.25441783
NSC 658370 Null 0.0385067071027345 0.37095897
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0385067071027345 0.062798131
NSC 665484 Null 0.0385067071027345 0.40640492
NSC 671119 Null 0.0385067071027345 0.44841776
NSC 671165 Null 0.0385067071027345 0.39948537
NSC 674067 stereoisomer of NSC 674066-O 0.0385067071027345 0.37122148
NSC 676343 Null 0.0385067071027345 0.18729955
NSC 678401 Glycine, N-[N-[[(4-methoxyphenyl)azo]carbonyl]-L-leucyl]-, dicyclohexylamine salt 0.0385067071027345 0.81533322
Total:97  Current:76    [First] [Prev] [Next] [Last]